Sign in

CIK 0001534120

  • Non-accelerated filer
  • Smaller reporting company

Avalo Therapeutics, Inc.

Sign in to watch
Ticker
AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450705648
Phone
+1 410-522-8707
Business address
1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE, PA, 19087
Former names
Cerecor Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$395,474
in 3 filings, $395K under 10b5-1 plans

Net −$395,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 88 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-28 Goldman Jonathan Director Exercise or conversion +3,166 3,166
2026-03-28 Goldman Jonathan Director Exercise or conversion · Restricted Stock Units −3,166 3,167
2025-11-14 Goldman Jonathan Director Sale −3,167 $14.30 $45K 0
2025-11-14 Goldman Jonathan Director Exercise or conversion +8,200 $9.88 $81K 8,200
2025-11-14 Goldman Jonathan Director Sale −8,200 $14.35 $118K 0
2025-11-14 Goldman Jonathan Director Exercise or conversion · Stock Option (Right to Buy) −8,200 16,400
2025-06-17 Goldman Jonathan Director Grant or award · Stock Option (Right to Buy) +20,100 20,100
2025-03-28 Goldman Jonathan Director Exercise or conversion +3,167 3,167
2025-03-28 Goldman Jonathan Director Exercise or conversion · Restricted Stock Units −3,167 6,333
2024-08-13 Goldman Jonathan Director Grant or award · Stock Option (Right to Buy) +24,600 24,600
2024-08-13 Goldman Jonathan Director Grant or award · Restricted Stock Units +9,500 9,500

Page 1 of 1 · 11 trades